Author
Howard L. Adler
Also Known As
H. L. Adler, HOWARD ADLER, HOWARD L. ADLER, Howard Adler, Howard L Adler, Howard L. Adler
66
Publications
2K
Citations
19
H-Index
58
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 10 | 10 | 662 |
2 | Engineering | 3 | 3 | 85 |
3 | Health Sciences | 3 | 3 | 443 |
4 | Biomedical Engineering | 1 | 1 | 52 |
5 | Cell Biology | 1 | 1 | 90 |
Howard L. Adler
×
23
Publications
1.9K
Citations
18
H-Index
| Year | Citations | |
|---|---|---|
1999 | 381 | |
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Paul G. Richardson, Albert Oriol, Meral Beksaç, Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPharmacotherapy | 2019 | 375 |
1999 | 304 | |
2000 | 117 | |
2001 | 94 | |
2009 | 90 | |
2006 | 66 | |
1996 | 60 | |
2005 | 58 | |
2005 | 53 |
Page 1
Page 1